From Crisis to Clarity

Building the Agentic Enterprise
for Pharma & SMEs.

I combine the rigor of a Pharma Executive, the vision of a Strategic Investor, and the technical capability to build Custom AI Agents that solve complex operational problems.

Real Problems. Agentic Solutions.

Theory is easy. Execution in a crisis is hard. In 2025, I took over RB Pharma in a critical state: paralysis, financial distress, and a skeleton team.

Instead of traditional consulting, I deployed custom AI Agents to automate bureaucracy and clarify data, freeing me to focus on the human strategy.

"I don't just advise on AI. I build the agentic workflows that recover businesses."

The RB Pharma Turnaround (8 Months)

Revenue Generated
€1.2 Million
Verified
Team Reconstruction
2 8
High-Performance Elements
(Rebuilt from collapse; prev. 15 FTEs)
Tech Enabler
> Custom Agents for Treasury, Ops & Regulatory Compliance
> MVP "Wixmed" kept active and operational for internal team and beta test external clients
The Strategic Vision

The "Agentic Velocity" Model

Crisis management stabilizes the ship. This is where I steer it next. My Agentic Workflow model is designed to compress supply chain latency from days to hours.
(Interact below to see the target operating model)

Deploy Agents

Target Response Velocity

Standard Industry State: Manual processes bottlenecking the supply chain.

Target Velocity
168h

The Hybrid Profile

The ability to orchestrate this solution comes from a unique convergence of three distinct professional lives.

Competency Matrix

Academic & Strategic Foundation

Executive MBA
AESE Business School
Strategy
MSc Econ & Innovation
ISEG - Lisbon School of Econ
Policy
PharmD
ISCSEM
Science
2025

The Turnaround Strategist

RB Pharma (Executive Director)

Leveraged self-developed Agentic AI systems to navigate a complex crisis. Delivered €1.2M revenue and stabilized operations in record time.

2017 - 2025

The Corporate Agilist

Marketing Director at Cencora (prev. Alliance Healthcare)

Navigating a €750M multinational giant. Drove Strategic Marketing and Own Brands, proving that agility and value creation are possible even in complex corporate environments.

2013 - Present

The Entrepreneurial Investor

Portfolio: Atelier 560, Melt, Farmácia Idanha

Beyond strategic investment in Atelier 560, I drive value across sectors. Restructured Farmácia Idanha and created the retail brand 'Melt, enjoy it'. Building resilient assets with skin in the game.

2009 - 2013

The Intrapreneurial Shareholder

Grupo Holon (Shareholder & Unit Founder)

As a shareholder, I didn't just manage; I built. Founded new business units and drove expansion strategies, blending the roles of investor and operator.

1998 - 2009

The Scientific Foundation

PharmD & Research Scientist

Started in the lab as a Junior Research Scientist before moving to community pharmacy leadership. My approach to business is rooted in the rigorous scientific method.